Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)

Joos Meyer; Carly Fry; Angus Turner; Hessom Razavi

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)

Joos Meyer, Carly Fry, Angus Turner, Hessom Razavi

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	829-830
Number of pages	2
Journal	Clinical and Experimental Ophthalmology
Volume	49
Issue number	8
Publication status	Published - Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

1 Article

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The OASIS study (a randomised control trial)
Meyer, J., Fry, C., Turner, A. & Razavi, H., Jul 2022, In: Clinical and Experimental Ophthalmology. 50, 5, p. 522-533 12 p.
Research output: Contribution to journal › Article › peer-review
7 Citations (Scopus)

Cite this

@article{ecd817c7c490437d81784c9a27483cff,

title = "Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)",

author = "Joos Meyer and Carly Fry and Angus Turner and Hessom Razavi",

year = "2022",

month = feb,

language = "English",

volume = "49",

pages = "829--830",

journal = "Clinical and Experimental Ophthalmology",

issn = "1442-6404",

publisher = "John Wiley & Sons",

number = "8",

}

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial). / Meyer, Joos; Fry, Carly; Turner, Angus et al.
In: Clinical and Experimental Ophthalmology, Vol. 49, No. 8, 02.2022, p. 829-830.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)

AU - Meyer, Joos

AU - Fry, Carly

AU - Turner, Angus

AU - Razavi, Hessom

PY - 2022/2

Y1 - 2022/2

M3 - Abstract/Meeting Abstract

SN - 1442-6404

VL - 49

SP - 829

EP - 830

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

IS - 8

ER -

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema, the OASIS study (a randomised control trial)

UN SDGs

Research output

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The OASIS study (a randomised control trial)

Cite this